Table of Contents

1 Report Overview

• 1.1 Study Scope
• 1.2 Key Market Segments
• 1.3 Players Covered
• 1.4 Market Analysis by Type
  • 1.4.1 Global Lapatinib Market Size Growth Rate by Type (2014-2025)
  • 1.4.2 250 mg Tablets
  • 1.4.3 Type II
• 1.5 Market by Application
  • 1.5.1 Global Lapatinib Market Share by Application (2014-2025)
  • 1.5.2 Hospital
  • 1.5.3 Drug store
• 1.6 Study Objectives
• 1.7 Years Considered

2 Global Growth Trends

• 2.1 Lapatinib Market Size
• 2.2 Lapatinib Growth Trends by Regions
  • 2.2.1 Lapatinib Market Size by Regions (2014-2025)
  • 2.2.2 Lapatinib Market Share by Regions (2014-2019)
• 2.3 Industry Trends
  • 2.3.1 Market Top Trends
  • 2.3.2 Market Drivers
  • 2.3.3 Market Opportunities

3 Market Share by Key Players

• 3.1 Lapatinib Market Size by Manufacturers
  • 3.1.1 Global Lapatinib Revenue by Manufacturers (2014-2019)
  • 3.1.2 Global Lapatinib Revenue Market Share by Manufacturers (2014-2019)
  • 3.1.3 Global Lapatinib Market Concentration Ratio (CR5 and HHI)
• 3.2 Lapatinib Key Players Head office and Area Served
• 3.3 Key Players Lapatinib Product/Solution/Service
• 3.4 Date of Enter into Lapatinib Market
• 3.5 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type and Application

• 4.1 Global Lapatinib Market Size by Type (2014-2019)
• 4.2 Global Lapatinib Market Size by Application (2014-2019)

5 United States

• 5.1 United States Lapatinib Market Size (2014-2019)
• 5.2 Lapatinib Key Players in United States
• 5.3 United States Lapatinib Market Size by Type
• 5.4 United States Lapatinib Market Size by Application

6 Europe

• 6.1 Europe Lapatinib Market Size (2014-2019)
• 6.2 Lapatinib Key Players in Europe
• 6.3 Europe Lapatinib Market Size by Type
• 6.4 Europe Lapatinib Market Size by Application

7 China

• 7.1 China Lapatinib Market Size (2014-2019)
• 7.2 Lapatinib Key Players in China
• 7.3 China Lapatinib Market Size by Type
• 7.4 China Lapatinib Market Size by Application

8 Japan

• 8.1 Japan Lapatinib Market Size (2014-2019)
• 8.2 Lapatinib Key Players in Japan
• 8.3 Japan Lapatinib Market Size by Type
• 8.4 Japan Lapatinib Market Size by Application

9 Southeast Asia

• 9.1 Southeast Asia Lapatinib Market Size (2014-2019)
• 9.2 Lapatinib Key Players in Southeast Asia
• 9.3 Southeast Asia Lapatinib Market Size by Type
• 9.4 Southeast Asia Lapatinib Market Size by Application

10 India

• 10.1 India Lapatinib Market Size (2014-2019)
• 10.2 Lapatinib Key Players in India
• 10.3 India Lapatinib Market Size by Type
• 10.4 India Lapatinib Market Size by Application

11 Central & South America

• 11.1 Central & South America Lapatinib Market Size (2014-2019)
• 11.2 Lapatinib Key Players in Central & South America
• 11.3 Central & South America Lapatinib Market Size by Type
• 11.4 Central & South America Lapatinib Market Size by Application

12 International Players Profiles

• 12.1 Novartis
  • 12.1.1 Novartis Company Details
  • 12.1.2 Company Description and Business Overview
  • 12.1.3 Lapatinib Introduction
  • 12.1.4 Novartis Revenue in Lapatinib Business (2014-2019)
  • 12.1.5 Novartis Recent Development

13 Market Forecast 2019-2025

• 13.1 Market Size Forecast by Regions
• 13.2 United States
• 13.3 Europe
• 13.4 China
• 13.5 Japan
• 13.6 Southeast Asia
• 13.7 India
• 13.8 Central & South America
• 13.9 Market Size Forecast by Product (2019-2025)
• 13.10 Market Size Forecast by Application (2019-2025)

14 Analyst's Viewpoints/Conclusions

15 Appendix

• 15.1 Research Methodology
  • 15.1.1 Methodology/Research Approach
    • 15.1.1.1 Research Programs/Design
    • 15.1.1.2 Market Size Estimation
    • 12.1.1.3 Market Breakdown and Data Triangulation
  • 15.1.2 Data Source
    • 15.1.2.1 Secondary Sources
    • 15.1.2.2 Primary Sources
• 15.2 Disclaimer

Lapatinib (INN), used in the form of lapatinib ditosylate (USAN) (trade names Tykerb and Tyverb) is an orally active drug for breast cancer and other solid tumours.
In 2018, the global Lapatinib market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.

This report focuses on the global Lapatinib status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Lapatinib development in United States, Europe and China.

The key players covered in this study
Novartis
...

Market segment by Type, the product can be split into
250 mg Tablets
Type II

Market segment by Application, split into
Hospital
Drug store

Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America

The study objectives of this report are:
To analyze global Lapatinib status, future forecast, growth opportunity, key market and key players.
To present the Lapatinib development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.

In this study, the years considered to estimate the market size of Lapatinib are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.